Alexander C. Herzick

Before joining THP in 2009, Alex worked in Business Development in the Oncology/Multiple Sclerosis Group at Genzyme Corporation. At Genzyme, he structured licensing and M&A transactions in the biotechnology and pharmaceuticals space. He also worked as a Portfolio Manager at BlueMountain Capital Management and as an Analyst in Investment Banking at Bank of America Securities. In 2021, he moved to North Carolina from San Francisco to open THP’s Research Triangle office. He has represented THP on the boards of Argonaut Manufacturing Services, Carterra, Cell Microsystems, Community Bio, Dynex Technologies, and Teknova (NASDAQ: TKNO). He was a board observer at Agena Bioscience (acquired by Mesa Laboratories). Alex holds an MBA with honors from Kellogg School of Management at Northwestern University and a Bachelor of Science in Economics with a Minor in Molecular and Cellular Biology from Duke University.